Drug Target Review

JULY 13, 2023

The aim is to establish condensate biology as a fundamental branch of cell biology – “cell biology 2.0” The underlying biology and processes upon which the company was founded have broad applicability across various human disease areas. Klein notes the importance of Dewpoint’s disease-agnostic approach.

Disease 98

Disease Small Molecule Cell Biology Drugs 98

Drug Target Review

JULY 23, 2024

I sharpened my focus in my early teen age years when I decided I wanted to harness my interest in human biology to make medicines for people. I studied Natural Sciences at the University of Cambridge, where I was exposed to a range of disciplines from chemistry to physiology, specialising in my last year in biochemistry.

Small Molecule 116

Small Molecule Targeted Protein Degradation Science Disease 116

Drug Target Review

JULY 31, 2023

I was ‘pre-med’ and got really interested in the science and especially the integration of chemistry and art. I struggled with going to graduate school in art conservation science, ie, the science of art, or more general chemistry, and I decided to do chemistry because it had broader opportunities. Integration is really the key.

DNA 98

DNA Small Molecule Science Cell Biology 98

NIH Director's Blog: Drug Discovery

APRIL 11, 2017

Credit: National Center for Advancing Translational Sciences, NIH When you think of the causes of infectious diseases, what first comes to mind are probably viruses and bacteria. Missing was the usual pocket-shaped active site, where a traditional small molecule can readily bind and block function. ” [1] Or was it?

Small Molecule 52

Small Molecule Science Drug Development Disease 52

Drug Target Review

AUGUST 10, 2023

This discovery sheds new light on the intricate mechanisms at play within cancer cells when faced with adverse conditions. When bound to GRP78, ID2 loses its inhibitory function, leading to increased invasiveness of cancer cells.

Cell Biology 52

Cell Biology Small Molecule Regulations Engineering 52

Elrig

APRIL 29, 2024

My role involved generating and characterizing complex proteins critical for biological assay development, hit discovery, and structural biology. During this time, I had the opportunity to step in as an interim Discovery Sciences project lead, sparking my interest in project leadership.

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

The Pharma Data

OCTOBER 19, 2020

At Aduro, he was responsible for all manufacturing and supply chain activities for the company’s biologics and small molecules and managed a transatlantic team. in Cell Biology from Utrecht University. UTRECHT, The Netherlands–( BUSINESS WIRE )– AM-Pharma B.V. , Kenilworth, N.J., Dr. van de Laar holds a M.Sc.

Trials 40

Trials Small Molecule Cell Biology Clinical Trials 40